BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36832161)

  • 1. O-RADS Classification for Ultrasound Assessment of Adnexal Masses: Agreement between IOTA Lexicon and ADNEX Model for Assigning Risk Group.
    Vara J; Pagliuca M; Springer S; Gonzalez de Canales J; Brotons I; Yakcich J; Ajossa S; Pascual MA; Guerriero S; Alcazar JL
    Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
    Hiett AK; Sonek JD; Guy M; Reid TJ
    Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of International Ovarian Tumor Analysis ADNEX model and Ovarian-Adnexal Reporting and Data System with final histological diagnosis in adnexal masses: a retrospective study.
    Filiz AA; Kahyaoglu S; Atalay CR
    Obstet Gynecol Sci; 2024 Jan; 67(1):86-93. PubMed ID: 37822234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Ultrasound Scores in Differentiating between Benign and Malignant Adnexal Masses.
    Pelayo M; Pelayo-Delgado I; Sancho-Sauco J; Sanchez-Zurdo J; Abarca-Martinez L; Corraliza-Galán V; Martin-Gromaz C; Pablos-Antona MJ; Zurita-Calvo J; Alcázar JL
    Diagnostics (Basel); 2023 Mar; 13(7):. PubMed ID: 37046525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of Ultrasound Scores (Subjective Assessment, Simple Rules Risk Assessment, ADNEX Model, O-RADS) to Adnexal Masses of Difficult Classification.
    Pelayo M; Sancho-Sauco J; Sánchez-Zurdo J; Perez-Mies B; Abarca-Martínez L; Cancelo-Hidalgo MJ; Sainz-Bueno JA; Alcázar JL; Pelayo-Delgado I
    Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound Features and Ultrasound Scores in the Differentiation between Benign and Malignant Adnexal Masses.
    Pelayo M; Sancho-Sauco J; Sanchez-Zurdo J; Abarca-Martinez L; Borrero-Gonzalez C; Sainz-Bueno JA; Alcazar JL; Pelayo-Delgado I
    Diagnostics (Basel); 2023 Jun; 13(13):. PubMed ID: 37443546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective comparative trial comparing O-RADS, IOTA ADNEX model, and RMI score for preoperative evaluation of adnexal masses for prediction of ovarian cancer.
    Poonyakanok V; Tanmahasamut P; Jaishuen A
    J Obstet Gynaecol Res; 2023 May; 49(5):1412-1417. PubMed ID: 36895122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of ADNEX and IOTA two-step strategy and estimation of risk of complications during follow-up of adnexal masses in low-risk population.
    Pascual MA; Vancraeynest L; Timmerman S; Ceusters J; Ledger A; Graupera B; Rodriguez I; Valero B; Landolfo C; Testa AC; Bourne T; Timmerman D; Valentin L; Van Calster B; Froyman W
    Ultrasound Obstet Gynecol; 2024 Mar; ():. PubMed ID: 38477179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of O-RADS, GI-RADS, and ADNEX for Diagnosis of Adnexal Masses: An External Validation Study Conducted by Junior Sonologists.
    Lai HW; Lyu GR; Kang Z; Li LY; Zhang Y; Huang YJ
    J Ultrasound Med; 2022 Jun; 41(6):1497-1507. PubMed ID: 34549454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective external validation of IOTA methods for classifying adnexal masses and retrospective assessment of two-step strategy using benign descriptors and ADNEX: a Portuguese multicenter study.
    Borges AL; Brito M; Ambrósio P; Condeço R; Pinto P; Ambrósio B; Mahomed F; Gama JMR; Bernardo MJ; Gouveia AI; Djokovic D
    Ultrasound Obstet Gynecol; 2024 Mar; ():. PubMed ID: 38477149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External Validation of the Ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors Into O-RADS Risk Groups.
    Timmerman S; Valentin L; Ceusters J; Testa AC; Landolfo C; Sladkevicius P; Van Holsbeke C; Domali E; Fruscio R; Epstein E; Franchi D; Kudla MJ; Chiappa V; Alcazar JL; Leone FPG; Buonomo F; Coccia ME; Guerriero S; Deo N; Jokubkiene L; Kaijser J; Scambia G; Andreotti R; Timmerman D; Bourne T; Van Calster B; Froyman W
    JAMA Oncol; 2023 Feb; 9(2):225-233. PubMed ID: 36520422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interobserver agreement between eight observers using IOTA simple rules and O-RADS lexicon descriptors for adnexal masses.
    Antil N; Raghu PR; Shen L; Tiyarattanachai T; Chang EM; Ferguson CWK; Ho AA; Lutz AM; Mariano AJ; Morimoto LN; Kamaya A
    Abdom Radiol (NY); 2022 Sep; 47(9):3318-3326. PubMed ID: 35763052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Performance of Ultrasonography-Based Risk Models in Differentiating Between Benign and Malignant Ovarian Tumors in a US Cohort.
    Yoeli-Bik R; Longman RE; Wroblewski K; Weigert M; Abramowicz JS; Lengyel E
    JAMA Netw Open; 2023 Jul; 6(7):e2323289. PubMed ID: 37440228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the risk of malignancy in adnexal masses: validation of O-RADS and comparison with ADNEX model, SA, and RMI.
    Wang R; Yang Z
    Ginekol Pol; 2023; 94(10):799-806. PubMed ID: 36929789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-Step Strategy for Optimizing the Preoperative Classification of Adnexal Masses in a University Hospital, Using International Ovarian Tumor Analysis Models: Simple Rules and Assessment of Different NEoplasias in the adneXa Model.
    Esquivel Villabona AL; Rodríguez JN; Ayala N; Buriticá C; Gómez AC; Velandia AM; Rodríguez N; Alcázar JL
    J Ultrasound Med; 2022 Feb; 41(2):471-482. PubMed ID: 33890698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of O-RADS, GI-RADS, and IOTA simple rules regarding malignancy rate, validity, and reliability for diagnosis of adnexal masses.
    Basha MAA; Metwally MI; Gamil SA; Khater HM; Aly SA; El Sammak AA; Zaitoun MMA; Khattab EM; Azmy TM; Alayouty NA; Mohey N; Almassry HN; Yousef HY; Ibrahim SA; Mohamed EA; Mohamed AEM; Afifi AHM; Harb OA; Algazzar HY
    Eur Radiol; 2021 Feb; 31(2):674-684. PubMed ID: 32809166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the O-RADS and ADNEX models regarding malignancy rate and validity in evaluating adnexal lesions.
    Chen GY; Hsu TF; Chan IS; Liu CH; Chao WT; Shih YC; Jiang LY; Chang YH; Wang PH; Chen YJ
    Eur Radiol; 2022 Nov; 32(11):7854-7864. PubMed ID: 35583711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Study of the Efficacy of the Ovarian-Adnexa Reporting and Data System Ultrasound Combined With Contrast-Enhanced Ultrasound and the ADNEX MR Scoring System in the Diagnosis of Adnexal Masses.
    Wang T; Cui W; Nie F; Huang X; Huang L; Liu L; Zhu Y; Zheng R
    Ultrasound Med Biol; 2023 Sep; 49(9):2072-2080. PubMed ID: 37321953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of IOTA Simple Rules, IOTA ADNEX Model, RMI, and Subjective Assessment for Preoperative Adnexal Mass Evaluation: The Experience of a Tertiary Care Referral Hospital.
    Vilendecic Z; Radojevic M; Stefanovic K; Dotlic J; Likic Ladjevic I; Dugalic S; Stefanovic A
    Gynecol Obstet Invest; 2023; 88(2):116-122. PubMed ID: 36716716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subjective assessment and IOTA ADNEX model in evaluation of adnexal masses in patients with history of breast cancer.
    Pozzati F; Sassu CM; Marini G; Mascilini F; Biscione A; Giannarelli D; Garganese G; Fragomeni SM; Scambia G; Testa AC; Moro F
    Ultrasound Obstet Gynecol; 2023 Oct; 62(4):594-602. PubMed ID: 37204769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.